Hemopoietic growth factors and marrow transplantation: an overview.
Current clinical trials suggest that use of G-CSF and GM-CSF is likely to benefit marrow transplant patients by significantly reducing the duration of post-transplant leukopenia. It remains to be determined whether the use of megakaryocyte-active growth factors (e.g., Multi-CSF) will prove of value in elevating platelet levels in such patients.
Metcalf
D
D
Walter and Eliza Hall Institute, Royal Melbourne Hospital, Victoria, Australia.
D000818:Animals; D001853:Bone Marrow / Q000502:physiology; D016026:Bone Marrow Transplantation; D003115:Colony-Stimulating Factors; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans
D003115:Colony-Stimulating Factors